Pharmacy Focus
Pharmacy Times
Add to My Podcasts
Episodes
About
Reviews
Promote
S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
33 minutes
Posted Jul 30, 2025 at 8:33 pm.
0:00
33:45
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.
Previous
S2 Ep58: Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
Next
S2 Ep60: Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
← See all 349 episodes of Pharmacy Focus
